Intrathecal immune activation is associated with cerebrospinal fluid markers of neuronal destruction in AIDS patients

Journal of Neuroimmunology

Volumn 102, Issue 1, 2000, Pages 51-55

  Hagberg, Lars ^a   Fuchs, Dietmar ^b   Rosengren, Lars ^a   Gisslén, Magnus ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Cerebrospinal fluid; Human immunodeficiency virus; Intrathecal immune activation; Neurofilament

Indexed keywords

BIOCHEMICAL MARKER; DIDANOSINE; NEOPTERIN; NEUROFILAMENT PROTEIN; VIRUS RNA; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; CELL ACTIVATION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOCOMPETENT CELL; MALE; NERVE CELL LESION; PRIORITY JOURNAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BIOLOGICAL MARKERS; CELL DEATH; FEMALE; HIV; HIV INFECTIONS; HUMANS; IMMUNE SYSTEM; MALE; MIDDLE AGED; NEOPTERIN; NEUROFILAMENT PROTEINS; NEURONS; RNA, VIRAL; SPINAL CORD;

EID: 0033992094     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00150-2     Document Type: Article

References (26)

1. American Academy of Neurology AIDS Task Force Nomenclature and research case definitions for neurological manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Neurology. 41:1991;778-785.
2. Bagasra O., Lavi E., Bobroski L.et al. Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS. 10:1996;573-585.
3. Brew B.J., Dunbar N., Pemberton L., Kaldor J. Cerebrospinal fluid concentrations of β-2 microglobulin and neopterin predict the development of AIDS dementia complex. J. Infect. Dis. 174:1996;294-298.
4. Foudraine N.A., Hoetelmans R.M.W., Lange J.M.A., de Wolf F., van Benthem B.H.B., Maas J.J., Keet I.P.M., Portegies P. Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine. Lancet. 351:1998;1547-1551.
5. Gisslén M., Hagberg L., Norkrans G., Lekman A., Fredman P. Increased cerebrospinal fluid ganglioside GM-1 concentrations indicating neuronal involvement in all stages of HIV-1 infection. J. NeuroVirol. 3:1997;148-152.
6. Gisslén M., Norkrans G., Svennerholm B., Hagberg L. The effect on human immunodeficiency virus type 1 RNA levels in cerebrospinal fluid after initiation of zidovudine or didanosine. J. Infect. Dis. 175:1997;434-437.
7. Gisslén M., Norkrans G., Svennerholm B., Hagberg L. HIV-1 RNA is detectable with ultrasensitive quantitative polymerase chain reaction in plasma but not in cerebrospinal fluid during combination treatment with zidovudine, lamivudine and indinavir. AIDS. 12:1998;114-115.
8. Gisslén M., Svennerholm B., Fuchs D., Hagberg L. Neurological efficacy of stavudine, zidovudine, and lamivudine. Lancet. 352:1998;402-403.
9. Heyes M., Brew B., Martin A., Price R.W., Salazar A.M., Sidtis J.J., Yergey J.A., Mouradian M.M., Sadler A.E., Keilp J., Rubinow D., Markey S.P. Quinolonic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann. Neurol. 29:1991;202-209.
10. Holmberg B., Rosengren L.E., Karlsson J.-E., Johnels B. Increased cerebrospinal fluid of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease. Movement Disorder. 1:1998;70-77.
11. Lasek, R.J., 1988. In: Lasek, R.J., Black, M.M. (Eds.), Studying the Intrinsic Determinants of Neuronal Form and Function in Intrinsic Determinants of Neuronal Form and Function. Alan R. Liss, New York, pp. 1-60.
12. Lycke L., Karlsson J.-E., Andersen O., Rosengren L. Neurofilament protein in cerebrospinal fluid levels: a potential marker of activity in multiple sclerosis. J. Neurol., Neurosurg. Psychiatry. 64:1998;402-404.
13. Martin C., Albert J., Hansson P., Pehrsson P.O., Link H., Sönnerborg A. Cerebrospinal fluid mononuclear cell counts influence CSF HIV-1 RNA levels. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 17:1998;214-219.
14. McArthur J.C., McClernon D.R., Cronin M.F., Nance-Sproson T.E., Saah A.J., St. Clair M., Lanier E.R. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Ann. Neurol. 42:1997;689-698.
15. Monte de la S.M., Ho D.D., Schooley R.T., Hirsch M.S., Richardson E.P. Subacute encephalomyelitis of AIDS and its relation to HTLV-III infection. Neurology. 37:1987;562-569.
16. Morgello S., Cho E.S., Nielsen S., Devinsky O., Petito C.K. Cytomegalovirus encephalitis in patients with acquired immunodeficiency syndrome: an autopsy study of 30 cases and a review of the literature. Hum. Pathol. 18:1987;289-297.
17. Navia B., Jordan B., Price R. The AIDS dementia complex: clinical features. Ann. Neurol. 19:1986;517-524.
18. Navia B., Cho E.-S., Petito C., Price R. The AIDS dementia complex: II. Neuropathology. Ann. Neurol. 19:1986;525-535.
19. Pemberton L.A., Kerr S.J., Smythe G., Brew B.J. Quinolinic acid production by macrophages stimulated with IFN-gamma, TNF-alfa and IFN-alfa. J. Interferon Cytokine Res. 17:1997;589-595.
20. Rosengren L., Karlsson J.-E., Karlsson J.-O., Persson L.I., Wikkelsø C. Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament proteins in CSF. J. Neurochem. 67:1996;2017-2020.
21. Rosengren L.E., Karlsson J.-E., Sjögren M., Blennow K., Wallin A. Levels of neurofilament in CSF are increased in dementia. Neurology. 52:1999;1090-1097.
22. Sharer L.R., Saito Y., Da Cunha A., Ung P.C., Gelbard H.A., Epstein L.G., Blumberg B.M. In situ amplification and detection of HIV-1 DNA in fixed pediatric AIDS brain tissue. Hum. Pathol. 6:1996;614-617.
23. Steinert P.M., Roop D.R. Molecular and cellular biology of intermediate filaments. Annu. Rev. Biochem. 57:1988;593-625.
24. Studahl M., Ricksten A., Sandberg T., Elowson S., Herner S., Säll C., Bergström T. Cytomegalovirus infection of the CNS in non-compromised patients. Acta Neurol. Scand. 89:1994;451-457.
25. Tullberg M., Rosengren L., Blomserwall E., Karlsson J.-E., Wikkelsø C. CSF neurofilament and glial fibrillary acidic protein in normal pressure hydrocephalus. Neurology. 50:1998;1122-1127.
26. Wong J.K., Ignacio C.C., Torriani F., Havlir D., Fitch N.J.S., Richman D.D. In vivo compartmentalization of human immunodeficiency virus: evidence from the examination of pol sequences from autopsy tissues. J. Virol. 71:1997;2059-2071.